Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

MeSH terms

• Anti-HIV Agents / pharmacology
• Anti-HIV Agents / therapeutic use*
• Antiretroviral Therapy, Highly Active
• Antiviral Agents / pharmacology
• Antiviral Agents / therapeutic use*
• Drug Interactions
• Drug Therapy, Combination
• HIV Infections / complications
• HIV Infections / drug therapy*
• Hepatitis C / complications
• Hepatitis C / drug therapy*
• Humans
• Interferon-alpha / pharmacology
• Interferon-alpha / therapeutic use*
• Nucleosides / pharmacology
• Nucleosides / therapeutic use*
• Ribavirin / pharmacology
• Ribavirin / therapeutic use*